Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4
- PMID: 1706194
- PMCID: PMC1971846
- DOI: 10.1038/bjc.1991.91
Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4
Abstract
Monoclonal antibody (mAb) 83D4 was generated using formol-fixed paraffin-embedded human breast carcinoma tissue as the immunogen. Previous studies demonstrated that it was reactive with breast carcinoma tissues, but not with normal breast. The antigen identified by mAb 83D4 was detected, using ELISA, in MCF7 breast carcinoma cell line membrane extracts, in primary breast and colon carcinoma tissue extracts and in pleural effusion fluid from patients with metastatic breast cancer. No reactivity with 83D4 was found in either human milk fat globule membranes or skimmed milk. 83D4 reactive antigen was found to be a heterogeneous high molecular weight (MW) protein (apparent Mr:300-400 to over 1000 kDa) by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. The antigen was purified from MCF7 cells, breast and colon carcinomas and effusion fluid, by perchloric acid solubilisation followed by immunoaffinity chromatography with 83D4. The immunopurified antigen from MCF7 cells and pleural effusion fluid was further analysed by gel filtration and ion-exchange chromatography, which confirmed the high MW and indicated the charge heterogeneity of the reactive molecules. The 83D4 reactive antigen strongly bound to wheat-germ agglutinin and weakly to peanut lectin. No binding was found with lentil lectin or concanavalin A. Antigenic activity was strongly reduced by trypsin and subtilysin digestion and by treatment with sodium periodate, but it was not affected by neuraminidase. These results imply the glycoprotein nature of the 83D4-defined antigen and the involvement of carbohydrate, but probably not sialic acid, in the epitope. Purified 83D4 antigen did not display reactivity for mAb HMFG-1, directed against a polymorphic epithelial mucin, PEM, using ELISA, but bound mAb CC49 and weakly mAb B72.3, antibodies which define a tumour associated glycoprotein, TAG-72. Moreover CC49 and 83D4 showed similar reactivity pattern in immunoblotting assays. A double determinant radioimmunoassay confirmed that 83D4 antigen carries epitopes for mAb B72.3 and CC49. Competition radioimmunoassays clearly distinguished the 83D4 defined epitope from those recognised by B72.3 and CC49, demonstrating that antibody 83D4 identifies a unique epitope. It is suggested that the antigens identified by mAb 83D4 and by mAb B72.3 and CC49 may form part of the same family of carcinoma associated glycoproteins.
Similar articles
-
Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.Breast Cancer Res Treat. 1994;32(2):139-52. doi: 10.1007/BF00665765. Breast Cancer Res Treat. 1994. PMID: 7532464
-
Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.Br J Cancer. 1989 Apr;59(4):544-53. doi: 10.1038/bjc.1989.111. Br J Cancer. 1989. PMID: 2469454 Free PMC article.
-
Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.Cancer Res. 1988 Dec 1;48(23):6811-8. Cancer Res. 1988. PMID: 3180090
-
Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.Acta Cytol. 1987 Sep-Oct;31(5):537-56. Acta Cytol. 1987. PMID: 3314301 Review.
-
Applications of immunocytochemistry to clinical cytology.Cancer Invest. 1987;5(6):593-611. doi: 10.3109/07357908709020319. Cancer Invest. 1987. PMID: 3327572 Review.
Cited by
-
Monoclonal 3C6F9 distribution in human breast carcinomas: image cytometry of immunocytochemical assays.Med Oncol Tumor Pharmacother. 1991;8(4):243-51. doi: 10.1007/BF02987193. Med Oncol Tumor Pharmacother. 1991. PMID: 1820490
-
Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.J Clin Pathol. 1995 May;48(5):433-7. doi: 10.1136/jcp.48.5.433. J Clin Pathol. 1995. PMID: 7629290 Free PMC article.
-
Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer.J Cancer Res Clin Oncol. 2023 Aug;149(9):6411-6434. doi: 10.1007/s00432-023-04626-0. Epub 2023 Feb 9. J Cancer Res Clin Oncol. 2023. PMID: 36757621 Free PMC article.
-
Combination effect on HIV infection in vitro of soluble CD4 and HIV-neutralizing antibodies.Arch Virol. 1994;134(1-2):179-84. doi: 10.1007/BF01379116. Arch Virol. 1994. PMID: 8279954
-
Characterization of a human cervical carcinoma-associated antigen by lectin binding and immuno-electron microscopy.Histochemistry. 1992 Jul;97(6):453-61. doi: 10.1007/BF00316064. Histochemistry. 1992. PMID: 1429005
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials